Cowen Starts Acadia Pharmaceuticals (ACAD) at Outperform
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $25.03 -1.84%
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 22 | New: 8
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 22 | New: 8
Join SI Premium – FREE
Cowen initiated coverage on Acadia Pharmaceuticals (NASDAQ: ACAD) with an Outperform rating and a price target of $46.00.
For an analyst ratings summary and ratings history on Acadia Pharmaceuticals click here. For more ratings news on Acadia Pharmaceuticals click here.
Shares of Acadia Pharmaceuticals closed at $27.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Starts Elevra Lithium (ELV:AU) at Buy
- Bernstein SocGen Group Starts Wuxi Apptec (2359:HK) (WUXIF) at Outperform
- TD Cowen Assumes MTY Food Group Inc. (MTY:CN) (MTYFF) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
